De-intensification of basal-bolus insulin regimen after initiation of a GLP-1 RA improves glycaemic control and promotes weight loss in subjects with type 2 diabetes-Reference-Cited by-同舟云学术

De-intensification of basal-bolus insulin regimen after initiation of a GLP-1 RA improves glycaemic control and promotes weight loss in subjects with type 2 diabetes

Published:2022-09-27 Issue:1 Volume:60 Page:53-60
ISSN:1432-5233
Container-title:Acta Diabetologica
language:en
Short-container-title:Acta Diabetol

Author:

Falcetta Pierpaolo,Nicolì Francesca,Citro Fabrizia,Ciccarone Annamaria,Garofolo Monia,Del Prato Stefano,Bianchi Cristina^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00592-022-01974-0.pdf

Reference21 articles.

1. Care D, Suppl SS (2022) 9 Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes. Diabetes Care 45:S125–S143. https://doi.org/10.2337/dc22-S009

2. Basu S, Yudkin JS, Kehlenbrink S, Davies JI, Wild SH, Lipska KJ et al (2019) Estimation of globalinsulin use for type 2 diabetes, 2018–30: a microsimulation analysis. Lancet Diabetes Endocrinol 7:25–33. https://doi.org/10.1016/S2213-8587(18)30303-6

3. Davies MJ, D’Alessio DA, Fradkin J, Kernan WN, Mathieu C, Mingrone G et al (2018) Management of hyperglycaemia in type 2 diabetes a consensus report by the American diabetes association (ADA) and the European association for the study of diabetes (EASD). Diabetologia 61(12):2461–2498. https://doi.org/10.2337/dci18-0033

4. Buse JB, Wexler DJ, Tsapas A, Rossing P, Mingrone G, Mathieu C et al (2020) Erratum: 2019 updateto: Management of hyperglycemia in type 2 diabetes, 2018 A consensus report by the American diabetes association (ADA) and the European association for the study of diabetes (EASD). Diabetes Care 43(2):487–493. https://doi.org/10.2337/dc20-er07

5. Diamant M, Nauck MA, Shaginian R, Malone JK, Cleall S, Reaney M et al (2014) Glucagon-likepeptide 1 receptor agonist or bolus insulin with optimized basal insulin in type 2 diabetes. Diabetes Care 37:2763–2773. https://doi.org/10.2337/dc14-0876

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endoscopic duodenal mucosa ablation techniques for diabetes and nonalcoholic fatty liver disease: A systematic review;Med;2024-07

2. De-intensification as a new trend in the treatment of type 2;FOCUS. Endocrinology;2024-05-13

3. News in insulin treatment;Vnitřní lékařství;2024-02-26